Tonix Pharmaceuticals Holding Corp’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $22.14 on 12/19/23, with the lowest value being $0.12 on 10/03/24.
52-week price history of TNXP Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Tonix Pharmaceuticals Holding Corp’s current trading price is -99.10% away from its 52-week high, while its distance from the 52-week low is 68.81%. The stock’s price range during this period has fluctuated between $0.12 and $22.14. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 12.49 million for the day, which was evidently lower than the average daily volume of 38.62 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Tonix Pharmaceuticals Holding Corp (TNXP) has experienced a quarterly decline of -46.74% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 37.23M and boasts a workforce of 103 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2939, with a change in price of -0.6947. Similarly, Tonix Pharmaceuticals Holding Corp recorded 30,466,188 in trading volume during the last 100 days, posting a change of -77.71%.
TNXP Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TNXP stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.08.
TNXP Stock Stochastic Average
Tonix Pharmaceuticals Holding Corp’s raw stochastic average for the past 50 days is currently at 51.36%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 48.63%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 47.65% and 46.97%, respectively.
TNXP Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The index has shown a price loss of -98.46% this year. Over the last six months, there has been a stronger performance of -96.45%. The price of TNXP fallen by 24.11% during the last 30 days period. For the last 5-days stocks have improved 51.95%.
